Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Osteoporosis Protection without Hormone Therapy

04.08.2004


Just a few years ago, hormone therapy was thought to be the best way to protect bone health during and after menopause. After menopause, your body no longer makes as much new bone as it did before -- setting the stage for osteoporosis.

Because research has revealed health risks associated with long-term hormone therapy, other medications have begun to emerge as better options for treating and preventing postmenopausal bone loss and fractures.

The August issue of Mayo Clinic Women’s HealthSource reviews medication options:



Bisphosphonates: This class of medications includes alendronate (Fosamax) and risedronate (Actonel). Both can preserve bone mass and moderately increase bone density in your spine and hips. A recent study showed that alendronate increased bone mineral density in the spine continuously over a 10-year period.

Raloxifene (Evista): This medication belongs to a class of drugs called selective estrogen receptor modulators. It mimics estrogen’s beneficial effects on bone density without some of the risks associated with estrogen. Studies have shown that after three years of use, raloxifene reduced the risk of spine injuries by 36 percent.

Calcitonin (Miacalcin): This drug works by slowing the breakdown of bone and helps keep bone density stable. It’s used as a nasal spray or by injection.

Teriparatide (Forteo): This is the first of a new category of medications called anabolic agents. Unlike other drugs that are used to prevent bone loss, teriparatide stimulates bone formation. Taken by daily injection, its long-term effectiveness and safety are still being studied.

Mayo Clinic Women’s HealthSource is published monthly to help women enjoy healthier, more productive lives. Revenue from subscriptions is used to support medical research at Mayo Clinic. To subscribe, please call 800-876-8633, extension 9PK1.

| newswise
Further information:
http://www.mayo.edu

More articles from Health and Medicine:

nachricht New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University

nachricht Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

Im Focus: Nanorobots propel through the eye

Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.

Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

In focus: Peptides, the “little brothers and sisters” of proteins

12.11.2018 | Life Sciences

Materials scientist creates fabric alternative to batteries for wearable devices

12.11.2018 | Materials Sciences

A two-atom quantum duet

12.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>